Alexandra Mancini
2022
In 2022, Alexandra Mancini earned a total compensation of $290.5K as Senior Vice President, Clinical & Regulatory Affairs at InMed Pharmaceuticals, a 28% decrease compared to previous year.
Compensation breakdown
| Option Awards | $29,456 |
|---|---|
| Salary | $261,027 |
| Total | $290,483 |
Mancini received $261K in salary, accounting for 90% of the total pay in 2022.
Mancini also received $29.5K in option awards.
Rankings
In 2022, Alexandra Mancini's compensation ranked 5,070th out of 5,669 executives tracked by ExecPay. In other words, Mancini earned more than 10.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,070 out of 5,669 | 11th |
Division Manufacturing | 2,786 out of 3,081 | 10th |
Major group Chemicals And Allied Products | 1,296 out of 1,396 | 7th |
Industry group Drugs | 1,217 out of 1,297 | 6th |
Industry Pharmaceutical Preparations | 882 out of 940 | 6th |
Source: SEC filing on October 28, 2022.
Mancini's colleagues
We found four more compensation records of executives who worked with Alexandra Mancini at InMed Pharmaceuticals in 2022.
News
InMed Pharmaceuticals CEO Eric Adams' 2024 pay rises 13% to $415K
October 28, 2024
InMed Pharmaceuticals CEO Eric Adams' 2023 pay falls 22% to $368K
October 27, 2023
InMed Pharmaceuticals CEO Eric Adams' 2022 pay falls 36% to $468K
October 28, 2022
InMed Pharmaceuticals CEO Eric Adams' 2021 pay jumps 73% to $735K
October 28, 2021